FIELD: medicine. SUBSTANCE: method involves examining alpha tumor necrosis factor level in blood serum and tears taken from a healthy and injured eye in dynamic mode. The factor being absent in blood serum and tears fluid of both eyes, worsening clinical course with high probability of metastases is predicted. No factor being manifested, it is thought to be absolute indication in favor of applying adequate immunity correction treatment under control of immunological indices. EFFECT: high accuracy of prognosis; enhanced effectiveness of treatment course.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
| METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF LEIOMYOMA AND IRIS MELANOMA | 2001 |
|
RU2199124C1 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
| METHOD OF REVEALING LATENT METASTATIC SPREAD IN PATIENTS WITH UVEAL MELANOMA | 1998 |
|
RU2147373C1 |
| METHOD FOR DETERMINING INDICATIONS FOR MAKING RETINA LASER COAGULATION IN CASES OF DIABETIC RETINOPATHY | 1998 |
|
RU2146054C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
| METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
| METHOD OF REMOVING INTRAOCULAR TUMORS | 1999 |
|
RU2143874C1 |
